Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Mylan Insulin Glargine Study

ClinicalTrials.gov ID: NCT03376789

Public ClinicalTrials.gov record NCT03376789. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 27, 2026, 2:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multi-center, Double-Blind, Parallel-Group Clinical Study Comparing the Efficacy and Safety of MYL-1501D Produced by Two Manufacturing Processes in Type 1 Diabetes Mellitus Patients

Study identification

NCT ID
NCT03376789
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mylan Inc.
Industry
Enrollment
219 participants

Conditions and interventions

Interventions

  • MYL-1501D product using manufacture process V Drug
  • MYL-1501D product using manufacture process VI Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 28, 2017
Primary completion
Sep 24, 2018
Completion
Jan 9, 2019
Last update posted
Mar 2, 2022

2017 – 2019

United States locations

U.S. sites
38
U.S. states
8
U.S. cities
36
Facility City State ZIP Site status
Mylan Investigator Site Fresno California 93720
Mylan Investigator Site Greenbrae California 94904
Mylan Investigator Site Huntington Beach California 92648
Mylan Investigator Site La Mesa California 91942
Mylan Investigator Site Los Gatos California 95032
Mylan Investigator Site Mission Hills California 91345
Mylan Investigator Site Montclair California 91763
Mylan Investigator Site Northridge California 91324
Mylan Investigator Site Oakland California 94607
Mylan Investigator Site Santa Monica California 90404
Mylan Investigator Site Tarzana California 91356
Mylan Investigator Site Tustin California 92780
Mylan Investigator Site Walnut Creek California 94598
Mylan Investigator Site Denver Colorado 80246
Mylan Investigator Site Bradenton Florida 34201
Mylan Investigator Site Fort Lauderdale Florida 33312
Mylan Investigator Site Fort Myers Florida 33912
Mylan Investigator Site Hialeah Florida 33012
Mylan Investigator Site Maitland Florida 32751
Mylan Investigator Site Miami Florida 33126
Mylan Investigator Site Miami Florida 33156
Mylan Investigator Site Miami Florida 33175
Mylan Investigator Site New Port Richey Florida 34652
Mylan Investigator Site Palm Harbor Florida 34684
Mylan Investigator Site Spring Hill Florida 34609
Mylan Investigator Site St. Petersburg Florida 33709
Mylan Investigator Site Tampa Florida 33634
Mylan Investigator Site West Palm Beach Florida 33401
Mylan Investigator Site Atlanta Georgia 30318
Mylan Investigator Site Columbus Georgia 31904
Mylan Investigator Site Lawrenceville Georgia 30045
Mylan Investigator Site Roswell Georgia 30076
Mylan Investigator Site Idaho Falls Idaho 83404
Mylan Investigator Site Meridian Idaho 83642
Mylan Investigator Site Springfield Illinois 62701
Mylan Investigator Site Council Bluffs Iowa 51501
Mylan Investigator Site Austin Texas 78731
Mylan Investigator Site Dallas Texas 75231

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03376789, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2022 · Synced Jun 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03376789 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →